162 related articles for article (PubMed ID: 36782112)
1. Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up.
Chen CJ; Huang YH; Hsu CW; Chen YC; Chang ML; Lin CY; Shen YH; Chien RN
BMC Gastroenterol; 2023 Feb; 23(1):40. PubMed ID: 36782112
[TBL] [Abstract][Full Text] [Related]
2. Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.
Chen CT; Lu MY; Hsieh MH; Tsai PC; Hsieh TY; Yeh ML; Huang CI; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Huang CF; Huang JF; Dai CY; Chuang WL; Shih YL; Yu ML
World J Gastroenterol; 2022 Jan; 28(2):263-274. PubMed ID: 35110949
[TBL] [Abstract][Full Text] [Related]
3. Virological patterns of hepatitis C virus patients with failure to the current-generation direct-acting antivirals.
Pisaturo M; Starace M; Minichini C; De Pascalis S; Occhiello L; Fraia AD; Messina V; Sangiovanni V; Claar E; Coppola N;
Int J Antimicrob Agents; 2020 Sep; 56(3):106067. PubMed ID: 32599227
[TBL] [Abstract][Full Text] [Related]
4. REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.
Kracht PAM; Arends JE; van Erpecum KJ; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Wensing AMJ; Deege MPH; Dimmendaal M; Stadhouders PHGM; Friederich PW; Verhagen MAMT; Boland GJ; Hoepelman AIM
Liver Int; 2019 Mar; 39(3):455-462. PubMed ID: 30204289
[TBL] [Abstract][Full Text] [Related]
5. Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis.
Hsu PY; Wei YJ; Lee JJ; Niu SW; Huang JC; Hsu CT; Jang TY; Yeh ML; Huang CI; Liang PC; Lin YH; Hsieh MY; Hsieh MH; Chen SC; Dai CY; Lin ZY; Chen SC; Huang JF; Chang JM; Hwang SJ; Chuang WL; Huang CF; Chiu YW; Yu ML
Clin Mol Hepatol; 2021 Jan; 27(1):186-196. PubMed ID: 33317251
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
Tsertsvadze T; Gamkrelidze A; Nasrullah M; Sharvadze L; Morgan J; Shadaker S; Gvinjilia L; Butsashvili M; Metreveli D; Kerashvili V; Ezugbaia M; Chkhartishvili N; Abutidze A; Kvaratskhelia V; Averhoff F
BMC Infect Dis; 2020 Jan; 20(1):30. PubMed ID: 31924172
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R).
Stein K; Stoehr A; Klinker H; Teuber G; Naumann U; John C; Heyne R; Serfert Y; Niederau C; Zeuzem S; Berg T; Wiegand J;
Eur J Gastroenterol Hepatol; 2022 Jan; 34(1):76-83. PubMed ID: 32956186
[TBL] [Abstract][Full Text] [Related]
8. Retrospective multicentre study on the effectiveness of first-line direct-acting antivirals against hepatitis C virus genotype-1.
Kaya M; Nakamura K; Sugiyama K; Kinae A; Yamaguchi H; Ukita H; Odagiri K; Ujiie C; Kato J; Kageyama F; Nagura M; Matsushita K; Sugiue K; Ishida H; Endo S; Suzuki T
J Clin Pharm Ther; 2022 Jul; 47(7):940-947. PubMed ID: 35229326
[TBL] [Abstract][Full Text] [Related]
9. Retrieval of patients with hepatitis C who were lost to follow-up in Southern Denmark.
Dröse S; Hansen JF; Røge BT; Øvrehus ALH; Christensen PB
Infect Dis (Lond); 2023 May; 55(5):361-369. PubMed ID: 36930953
[TBL] [Abstract][Full Text] [Related]
10. Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03).
Wehmeyer MH; Ingiliz P; Christensen S; Hueppe D; Lutz T; Simon KG; Schewe K; Boesecke C; Baumgarten A; Busch H; Rockstroh J; Schmutz G; Kimhofer T; Berger F; Mauss S; Schulze Zur Wiesch J
J Med Virol; 2018 Feb; 90(2):304-312. PubMed ID: 28710853
[TBL] [Abstract][Full Text] [Related]
11. Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections.
Sun HY; Cheng CY; Lin CY; Yang CJ; Lee NY; Liou BH; Tang HJ; Liu YM; Lee CY; Chen TC; Huang YC; Lee YT; Tsai MJ; Lu PL; Tsai HC; Wang NC; Hung TC; Cheng SH; Hung CC
World J Gastroenterol; 2022 Mar; 28(11):1172-1183. PubMed ID: 35431505
[TBL] [Abstract][Full Text] [Related]
12. Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5.
Liu CH; Kao JH
Hepatol Int; 2022 Oct; 16(5):1001-1019. PubMed ID: 35876967
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination.
Isfordink CJ; van Dijk M; Brakenhoff SM; Kracht PAM; Arends JE; de Knegt RJ; van der Valk M; Drenth JPH;
Eur J Intern Med; 2022 Jul; 101():93-97. PubMed ID: 35527178
[TBL] [Abstract][Full Text] [Related]
14. Direct-Acting Antivirals to Prevent Vertical Transmission of Viral Hepatitis C: When Is the Optimal Time to Treat?
Cervino L; Hynicka LM
Ann Pharmacother; 2018 Nov; 52(11):1152-1157. PubMed ID: 29681166
[TBL] [Abstract][Full Text] [Related]
15. Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study.
Liu CH; Huang YJ; Yang SS; Chang CH; Yang SS; Sun HY; Liu CJ; Liu WC; Su TH; Yang HC; Hong CM; Tseng TC; Chen PJ; Chen DS; Hung CC; Kao JH
Sci Rep; 2018 Sep; 8(1):13699. PubMed ID: 30209349
[TBL] [Abstract][Full Text] [Related]
16. Retrieval and re-evaluation of previously diagnosed chronic hepatitis C infections lost to medical follow-up in the Netherlands.
Heil J; Soufidi K; Stals F; Frantzen H; Robroek-Schaecken A; Bakker CM; van Nunen AB; Dukers-Muijrers NHTM; Hoebe CJPA
Eur J Gastroenterol Hepatol; 2020 Jul; 32(7):851-856. PubMed ID: 31688310
[TBL] [Abstract][Full Text] [Related]
17. Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021.
Martinez A; Khan T; Dylla DE; Marcinak J; Collins M; Saget B; Conway B
Harm Reduct J; 2023 Oct; 20(1):142. PubMed ID: 37779203
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C.
Isfordink CJ; Brakenhoff SM; van Dijk M; van der Valk M; de Knegt RJ; Arends JE; Drenth JP;
BMJ Open Gastroenterol; 2020; 7(1):e000396. PubMed ID: 32377367
[TBL] [Abstract][Full Text] [Related]
19. Retrieval of HCV patients lost to follow-up as a strategy for Hepatitis C Microelimination: results of a Brazilian multicentre study.
Ferraz MLG; de Andrade ARCF; Pereira GHS; Codes L; Bittencourt PL
BMC Infect Dis; 2023 Jul; 23(1):468. PubMed ID: 37442976
[TBL] [Abstract][Full Text] [Related]
20. A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan.
Kawaguchi I; Chayama K; Gonzalez YS; Virabhak S; Mitchell D; Yuen C; Kumada H
Adv Ther; 2020 Jan; 37(1):457-476. PubMed ID: 31808054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
